Your session is about to expire
← Back to Search
Vitamin Supplement
vitamin D supplement for Orthostatic Intolerance
N/A
Waitlist Available
Led By Hossam Shaltout, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
Study Summary
This trial is testing whether increasing vitamin D levels will help children with chronic nausea who have underlying cardiovascular problems.
Eligible Conditions
- Orthostatic Intolerance
- Vitamin D Deficiency
- Nausea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement of orthostatic intolerance symptoms usint tilt table test
Secondary outcome measures
improvement of nausea symptoms
Trial Design
1Treatment groups
Experimental Treatment
Group I: vitamin D supplementExperimental Treatment1 Intervention
patient's will be given a vitamin D
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
vitamin D supplement
2016
N/A
~110
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,004,206 Total Patients Enrolled
Hossam Shaltout, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
165 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger